lifestyle.marketresearchjournals.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
EIRGENIX INC.
EirGenix Signed The Commercial Licensinse Agreement for It’s Second HER2 Biosimilar Asset EG1206A
November 14, 2025
/C O R R E C T I O N — EirGenix, Inc./
November 14, 2025